Skip to content

Form 4 filed by David Matthew T

David Matthew T filed this Form 4 on ATNM (Actinium Pharmaceuticals, Inc.) with 2 transaction rows and 0 holding rows, accepted by EDGAR 2026-10-16 21:11:10 UTC.

Accession
0001213900-26-110340
Filed
2026-10-16
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

Issuer and reporting owners

Issuer: ATNM · Actinium Pharmaceuticals, Inc. (CIK 1388320)

Rows

SecurityDateCodeSharesPriceOwned afterOwnership
Common Stock 2026-10-14A granted+250,000$0250,000D
Stock Option (right to purchase) derivative2026-10-14A granted+250,000$0250,000D